Medicenna Therapeutics Corp Stock Buy Hold or Sell Recommendation
| MDNA Stock | CAD 1.72 0.06 3.37% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Medicenna Therapeutics Corp is 'Strong Sell'. The recommendation algorithm takes into account all of Medicenna Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Medicenna Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Medicenna and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Medicenna Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Medicenna |
Execute Medicenna Therapeutics Buy or Sell Advice
The Medicenna recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medicenna Therapeutics Corp. Macroaxis does not own or have any residual interests in Medicenna Therapeutics Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medicenna Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Medicenna Therapeutics Trading Alerts and Improvement Suggestions
| Medicenna Therapeutics generated a negative expected return over the last 90 days | |
| Medicenna Therapeutics has high historical volatility and very poor performance | |
| Medicenna Therapeutics may become a speculative penny stock | |
| Medicenna Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (25.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Medicenna Therapeutics Corp has accumulated about 33.6 M in cash with (16.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83. | |
| Roughly 22.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Medicennas MDNA11 Drug Shows 30 percent Response Rate, Strong Results in Cancer Trial MDNAF Stock News - StockTitan |
Medicenna Therapeutics Returns Distribution Density
The distribution of Medicenna Therapeutics' historical returns is an attempt to chart the uncertainty of Medicenna Therapeutics' future price movements. The chart of the probability distribution of Medicenna Therapeutics daily returns describes the distribution of returns around its average expected value. We use Medicenna Therapeutics Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medicenna Therapeutics returns is essential to provide solid investment advice for Medicenna Therapeutics.
| Mean Return | -0.14 | Value At Risk | -8.26 | Potential Upside | 7.66 | Standard Deviation | 5.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medicenna Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medicenna Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 20.3M | 7.7M | (9.8M) | 13.1M | (16.6M) | (15.8M) | |
| Free Cash Flow | (9.0M) | (15.3M) | (23.6M) | (12.7M) | (16.3M) | (15.4M) | |
| Depreciation | 7.9K | 40K | 38K | 4K | 4.6K | 4.4K | |
| Other Non Cash Items | (1.1M) | (15K) | (737K) | (975K) | 7.3M | 7.6M | |
| Net Income | (8.3M) | (17.3M) | (22.6M) | (10.0M) | (25.5M) | (24.2M) | |
| End Period Cash Flow | 22.7M | 30.4M | 20.5M | 33.6M | 17.0M | 15.0M | |
| Change To Netincome | 107.4K | 1.3M | 799K | (5.0M) | (5.8M) | (5.5M) | |
| Investments | (140.0K) | (354.5K) | (15M) | 5.0M | 10.1M | 0.0 |
Medicenna Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medicenna Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medicenna Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medicenna stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 1.02 | |
σ | Overall volatility | 5.12 | |
Ir | Information ratio | -0.05 |
Medicenna Therapeutics Volatility Alert
Medicenna Therapeutics Corp exhibits very low volatility with skewness of -0.26 and kurtosis of 0.86. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Medicenna Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Medicenna Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Medicenna Therapeutics Fundamentals Vs Peers
Comparing Medicenna Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medicenna Therapeutics' direct or indirect competition across all of the common fundamentals between Medicenna Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medicenna Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medicenna Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Medicenna Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Medicenna Therapeutics to competition |
| Fundamentals | Medicenna Therapeutics | Peer Average |
| Return On Equity | -1.05 | -0.31 |
| Return On Asset | -0.33 | -0.14 |
| Current Valuation | 108.87 M | 16.62 B |
| Shares Outstanding | 78.16 M | 571.82 M |
| Shares Owned By Insiders | 22.07 % | 10.09 % |
| Shares Owned By Institutions | 12.77 % | 39.21 % |
| Number Of Shares Shorted | 33.71 K | 4.71 M |
| Price To Book | 6.94 X | 9.51 X |
| EBITDA | (18.67 M) | 3.9 B |
| Net Income | (25.47 M) | 570.98 M |
| Cash And Equivalents | 33.6 M | 2.7 B |
| Cash Per Share | 0.83 X | 5.01 X |
| Total Debt | 13.94 M | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 26.75 X | 2.16 X |
| Book Value Per Share | 0.07 X | 1.93 K |
| Cash Flow From Operations | (16.26 M) | 971.22 M |
| Short Ratio | 0.55 X | 4.00 X |
| Earnings Per Share | (0.38) X | 3.12 X |
| Target Price | 5.0 | |
| Number Of Employees | 16 | 18.84 K |
| Beta | 1.19 | -0.15 |
| Market Capitalization | 134.43 M | 19.03 B |
| Total Asset | 19.13 M | 29.47 B |
| Retained Earnings | (106.45 M) | 9.33 B |
| Working Capital | 16.21 M | 1.48 B |
| Net Asset | 19.13 M |
Medicenna Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medicenna . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Medicenna Therapeutics Buy or Sell Advice
When is the right time to buy or sell Medicenna Therapeutics Corp? Buying financial instruments such as Medicenna Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medicenna Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Airlines Thematic Idea Now
Airlines
Domestic and international airlines and airline services. The Airlines theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Medicenna Stock
Medicenna Therapeutics financial ratios help investors to determine whether Medicenna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicenna with respect to the benefits of owning Medicenna Therapeutics security.